Time course of the changes in central nitric oxide synthase activity following chronic treatment with morphine in the mouse: Reversal by naltrexone

General Pharmacology

Volumn 29, Issue 2, 1997, Pages 223-227

  Kumar, Shailendra ^a   Bhargava, Hemendra N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Brain regions; Morphine tolerance dependence; Naltrexone; Nitric oxide synthase; Spinal cord; Time course

Indexed keywords

MORPHINE; NALTREXONE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; ENZYME ACTIVITY; MALE; MESENCEPHALON; MORPHINE ADDICTION; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN; KINETICS; MALE; MICE; MORPHINE; MORPHINE DEPENDENCE; NALTREXONE; NARCOTIC ANTAGONISTS; NITRIC OXIDE SYNTHASE; SPINAL CORD;

EID: 0030860734     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00416-8     Document Type: Article

References (36)

1. Babey A. M., Kolesnikov Y., Cheng J., Inturrisi C. E., Trifilletti R. R. and Pasternak G. W. (1994) Nitric oxide and opioid tolerance. Neuropharmacology 33, 1463-1470.
2. Barjavel M. J. and Bhargava H. N. (1994a) Effect of morphine tolerance and abstinence on nitric oxide synthase activity in brain regions and spinal cord of the mouse. Soc. Neurosci. Abstr. 20, A1234.
3. Barjavel M. J. and Bhargava H. N. (1994b) Effect of opioid receptor agonists on nitric oxide synthase activity in rat cerebral cortex homogenate. Neurosci. Lett. 181, 27-30.
4. Bhargava H. N. (1978) The effects of naltrexone on the development of physical dependence on morphine. Eur. J. Pharmac. 50, 193-202.
5. Bhargava H. N. ( 1980) The effect of thyrotrophin-releasing hormone on the central nervous system responses to chronic morphine administration. Psychopharmacology 68, 185-189.
6. Bhargava H. N. (1991) Multiple opioid receptors of brain and spinal cord in opioid addiction. Gen. Pharmac. 22, 767-772.
7. Bhatgava H. N. (1994a) Diversity of agents which modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behavior. Pharmac. Rev. 46, 293-324.
8. Bhargava H. N. (1994b) Nitric oxide synthase inhibitor blocks tolerance to the analgesic action of κ-opiate receptor agonists in the rat. Pharmacology 48, 234-241.
9. Bhargava H. N. (1995) Noncompetitive antagonism of NMDA receptor inhibits tolerance to U-50,488H, a κ-opioid receptor agonist in the rat. Gen. Pharmac. 26, 1055-1060.
10. Bhargava H. N. and Matwyshyn G. A. (1993) Dizocilpine (MK-801) blocks tolerance to its analgesic but not to the hyperthermic effect of morphine in the rat. Pharmacology 47, 344-350.
11. Bhargava H. N., Thomas P. T., Thorat S. N. and House R. V. (1994) Effect of morphine tolerance and abstinence on cellular immune function. Brain Res. 642, 1-10.
12. Bhargava H. N. and Thorat S. N. (1994) Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a κ-opioid receptor agonists, in the mouse. Brain Res. 649, 111-116.
13. Bhargava H. N. and Thorat S. N. (1996) Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome. Pharmacology 52, 86-91.
14. 2 opioid receptor agonist in mice. Brain Res. 719, 56-61.
15. Bhargava H. N. and Zhao G. M. (1996b) Effect of nitric oxide synthase inhibition on tolerance to the analgesic action of D-Pen2, D-Pen5 enkephalin and morphine in mice. Neuropeptides 30, 219-223.
16. Bredt D. S., Hwang P. M. and Snyder S. H. (1990) Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347, 768-770.
17. Bredt D. S. and Snyder S. H. (1992). Nitric oxide, a novel neuronal messenger. Neuron 8, 3-11.
18. Cappendijk S. L. T., DeVries R. and Dzoljic M. R. (1993). Inhibitory effect of nitric oxide (NO) synthase inhibitors on naloxone-precipitated withdrawal syndrome in morphine-dependent mice. Neurosci. Lett. 162, 97-100.
19. Garthwaite J. (1991) Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14, 60-67.
20. Johnson S. M. and Fleming W. W. (1989) Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence. Pharmac. Rev. 41, 435-488.
21. Kimes A. S., Vaupel D. B. and London E. D. (1993) Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology 112, 521-524.
22. Knowles R., Palacios M., Palmer R. M. J. and Moncada S. (1989) Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanisms for stimulation of the soluble guanylate cyclase. Proc. Natl. Acad. Sci. USA 86, 5159-5162.
23. G-nitro-L-arginine prevents morphine tolerance. Eur. J. Pharmac. 221, 399-400.
24. Leza J. C., Lizasoain I., San-Martin-Clark O. and Lorenzo P. (1995) Morphine-induced changes in cerebral and cerebellar nitric oxide synthase activity. Eur. J. Pharmac. 285, 95-98.
25. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
26. Marek P., Ben-Eliyahu S., Gold M. and Liebeskind J. C. (1991) Excitatory amino acid antagonists (Kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547, 77-81.
27. Moncada S., Palmer R. M. J. and Higgs E. A. (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmac. Rev. 43, 109-142.
28. Rasmussen K., Fuller R. W., Stockton M. E., Perry K. W., Swinford R. M. and Ornstein P. L. (1991) NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur. J. Pharmac. 197, 9-16.
29. Schmidt H. H. H. W., Wilke P., Evers B. and Bohme E. (1989) Enzymatic formation of nitric oxide from L-arginine in bovine brain cytosol. Biochem. Biophys. Res. Commun. 165, 284-291.
30. Snyder S. H. and Bredt D. S. (1991) Nitric oxide as a neuronal messenger. Trends Physiol. Sci. 12, 125-128.
31. G-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice. Brain Res. 642, 153-159.
32. Thorat S. N., Reddy P. L. and Bhargava H. N. (1993) Evidence for the role of nitric oxide in κ-opiate tolerance in mice. Brain Res. 621, 171-174.
33. Tiseo P. J. and Inturrisi C. E. (1993) Attenuation and reversal of morphine tolerance by the competitive N-methyi-D-aspartate receptor antagonist, LY274614. J. Pharmac. Exp. Ther. 264, 1090-1096.
34. Trujillo K. A. and Akil H. (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor agonist MK-801. Science 251, 85-87.
35. 1-opioid receptor agonist, Peptides 17, 233-236.
36. 4 deltorphin II in mice. Peptides 17, 619-623.